Application of ramectine in the preparation of anti-benign prostatic hyperplasia medicine

A technology for benign prostatic hyperplasia and ramistine, which is applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of high risk of surgical treatment, long treatment course, complicated pathogenesis, etc.
CN109700791BActive Publication Date: 2021-01-19XI AN JIAOTONG UNIV
1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
XI AN JIAOTONG UNIV
Publication Date
2021-01-19

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an application of caulophine in the preparation of a medicament for resisting benign prostatic hyperplasia. The present invention finds for the first time that caulophine has asignificant effect for resisting benign prostatic hyperplasia, and has mild and long-lasting effects. The invention provides a new choice and idea for the treatment of benign prostatic hyperplasia, and also contributes to the development of the technical field. The caulophine is a compound with a defined chemical structure, is available to quantifiable feed when used for preparing medicines, andis used for preparing modern dosage forms. The caulophine is highly safe and has the potential to develop into a drug for treating benign prostatic hyperplasia.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the new medical application of ramectine, in particular to the application of ramectine in the preparation of anti-benign prostatic hyperplasia medicine. Background technique

[0002] Benign prostatic hyperplasia is a common physiological lesion in elderly men. Its incidence is high, it is painful, and it is difficult to cure it. There is a substantial increase compared with the disease, and it has become one of the most common geriatric diseases among elderly men in my country.

[0003] The treatment of benign prostatic hyperplasia can be divided into surgical treatment and drug treatment. However, since most patients with benign prostatic hyperplasia are old, most patients may suffer from serious cardiovascular and cerebrovascular complications, and surgical treatment has a higher risk, so benign prostatic hyperplasia Drug treatment for prostate enlargement is very important.

[0004] At present, the drugs used clini...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More